This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Colgate-Palmolive (CL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 1.41% and 2.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors to Decide the Fate of Colgate (CL) in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) Q2 results are expected to reflect gains from strong consumer demand, innovation, premiumization, digital growth and robust pricing actions amid rising raw material and logistic costs.
Colgate-Palmolive (CL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Colgate-Palmolive (CL) closed at $77.85, marking a +0.49% move from the previous day.
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate-Palmolive (CL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Colgate-Palmolive (CL) closed the most recent trading day at $77.53, moving +0.53% from the previous trading session.
Factors Likely to Influence Boston Beer's (SAM) Q2 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are likely to reflect gains from a robust brand portfolio and strategic initiatives despite declines in shipments and depletions.
Colgate-Palmolive (CL) Stock Moves -0.5%: What You Should Know
by Zacks Equity Research
In the latest trading session, Colgate-Palmolive (CL) closed at $78.31, marking a -0.5% move from the previous day.
Can Colgate's (CL) Growth Efforts Offset Cost Headwinds?
by Zacks Equity Research
Despite raw material cost inflation, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Colgate-Palmolive (CL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Colgate-Palmolive (CL) closed at $74.04, marking a +0.16% move from the previous day.
Colgate-Palmolive (CL) Stock Moves -0.57%: What You Should Know
by Zacks Equity Research
Colgate-Palmolive (CL) closed at $76.19 in the latest trading session, marking a -0.57% move from the prior day.
New Strong Sell Stocks for June 7th
by Zacks Equity Research
CNMD, CL, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2022.
Colgate-Palmolive (CL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Colgate-Palmolive (CL) closed the most recent trading day at $78.78, moving -0.19% from the previous trading session.
New Strong Sell Stocks for June 3rd
by Zacks Equity Research
T, CL, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2022.
Clorox (CLX) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for May 17th
by Zacks Equity Research
CNMD, CL, and T have been added to the Zacks Rank #5 (Strong Sell) List on May 17, 2022.
Bear of the Day: ColgatePalmolive (CL)
by Jeremy Mullin
Costs adding up for this consumer staples stock.
Huntsman and Colgate-Palmolive have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Huntsman and Colgate-Palmolive have been highlighted as Zacks Bull and Bear of the Day
Core PCE Inflation at a 40-Year High in March
by Zacks Equity Research
Core PCE Inflation at a 40-Year High in March.
Colgate (CL) Meets Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Colgate's (CL) Q1 results reflect soft bottom-line performance on higher raw material and logistics costs despite the increased top line. Margins remain soft.
PCE +6.6%, Another 40-Year High; XOM, CL, BMY Report
by Mark Vickery
Inflation was clear and present in March, but a large chunk of it was due to food and energy prices.
Colgate-Palmolive (CL) Q1 Earnings Meet Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 0.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Church & Dwight (CHD) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 9.21% and 0.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's How Colgate (CL) is Poised Just Before Q1 Earnings
by Zacks Equity Research
Colgate's (CL) Q1 results are expected to reflect gains from strong consumer demand, innovation and expansion plans amid supply-chain disruptions, and rising raw material and logistics costs.
Earnings Preview: Colgate-Palmolive (CL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Coca-Cola (KO) Looks Poised for Q1 Earnings Beat
by Zacks Equity Research
Strength across the majority of the markets, investments in the marketplace and the cycling of last year's pandemic-led impacts are expected to have driven Coca-Cola's (KO) Q1 performance.